Literature DB >> 8031472

Complement C3 deficiency: human, animal, and experimental models.

L Singer1, H R Colten, R A Wetsel.   

Abstract

The third complement component (C3) is a multifunctional glycoprotein that interacts with numerous serum proteins, cell surface receptors, and membrane-associated regulatory proteins. Deficiencies of C3 have been reported in several human kindred of different ethnic backgrounds and from different geographic regions. In addition, inherited C3 deficiency has been discovered in certain strains of guinea pigs, dogs, and rabbits, and has been experimentally induced in animals by injections of cobra venom factor. Studies of the C3-deficient humans and animals have demonstrated the important roles performed by C3 in the immune response, opsonization and phagocytosis of pathogens, and immune complex solubilization. Current knowledge of the molecular and cellular basis of complement C3 deficiency indicates that C3 deficiency is caused by numerous molecular genetic mutations that include splicing defects, a partial gene deletion, and a critical amino acid substitution. With the advent of gene ablation technology, C3-deficient murine models can now be established, making it possible to examine the role that C3 plays in the molecular pathogenesis of many different diseases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8031472     DOI: 10.1159/000163873

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  12 in total

Review 1.  Animal models of inherited complement deficiency.

Authors:  S Linton
Journal:  Mol Biotechnol       Date:  2001-06       Impact factor: 2.695

2.  Role for complement in the development of seizures following acute viral infection.

Authors:  Jane E Libbey; Nikki J Kirkman; Karen S Wilcox; H Steve White; Robert S Fujinami
Journal:  J Virol       Date:  2010-04-28       Impact factor: 5.103

Review 3.  The yin and the yang of early classical pathway complement disorders.

Authors:  Kathleen E Sullivan
Journal:  Clin Exp Immunol       Date:  2022-08-19       Impact factor: 5.732

Review 4.  Complement modulation of T cell immune responses during homeostasis and disease.

Authors:  Elizabeth V Clarke; Andrea J Tenner
Journal:  J Leukoc Biol       Date:  2014-09-10       Impact factor: 4.962

Review 5.  The role of the alternative pathway of complement activation in glomerular diseases.

Authors:  Emilia Łukawska; Magdalena Polcyn-Adamczak; Zofia I Niemir
Journal:  Clin Exp Med       Date:  2018-02-15       Impact factor: 3.984

Review 6.  The guinea pig as a model of infectious diseases.

Authors:  Danielle J Padilla-Carlin; David N McMurray; Anthony J Hickey
Journal:  Comp Med       Date:  2008-08       Impact factor: 0.982

Review 7.  The cell biology of synapse formation.

Authors:  Thomas C Südhof
Journal:  J Cell Biol       Date:  2021-06-04       Impact factor: 10.539

Review 8.  Navigating the maze of complement genetics: a guide for clinicians.

Authors:  Harvey R Colten
Journal:  Curr Allergy Asthma Rep       Date:  2002-09       Impact factor: 4.919

9.  Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics.

Authors:  Peter Garred; Andrea J Tenner; Tom E Mollnes
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

10.  Screening for C3 deficiency in newborns using microarrays.

Authors:  Magdalena Janzi; Ronald Sjöberg; Jinghong Wan; Björn Fischler; Ulrika von Döbeln; Lourdes Isaac; Peter Nilsson; Lennart Hammarström
Journal:  PLoS One       Date:  2009-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.